real-world bortezomib prescribing patterns and outcomes in ndmm
Published 7 months ago • 30 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
1:25
real world data: bortezomib-based therapy for r/r myeloma
-
1:43
real-world outcomes of teclistamab for r/r multiple myeloma
-
1:30
real-world treatment patterns in third-line therapy for r/r myeloma
-
4:13
real-world study determining the safety and efficacy of teclistamab in r/r multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:53
real-world data on upfront subcutaneous bortezomib-containing regimens for newly diagnosed myeloma
-
1:36
relevance of panobinostat-bortezomib-dexamethasone in r/r myeloma in the era of novel agents
-
4:12
insight-mm: real-world patterns of patient characteristics
-
1:16
the evolving use of selinexor in multiple myeloma
-
3:00
current & emerging biomarkers in multiple myeloma
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:30
real-world insight for myeloma
-
1:01
car-t: myeloma toxicities
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
2:46
managing patients with high-risk myeloma
-
1:21
what is the pcrowd study, and how does knowledge in myeloma biology help with new treatments?